Trial intelligence / Profile preview

Neurobehavioral Mechanisms Linking Childhood Adversity to Increased Risk for Smoking

NCT05665465Phase 1Recruiting

Sponsor
Duke University
Start
Jan 2024
Primary completion
May 2027
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of nicotine patch (3 arms), sponsored by Duke University. Primary endpoints: Subjective effects of nicotine nasal spray as measured by the Nicotine Effects Questionnaire, Subjective effects of nicotine nasal spray as measured by a visual analog scale and 3 more. Started Jan 2024; status: recruiting.

02

Drugs

nicotine patch

Beyond the preview

Go deeper on NCT05665465.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05665465.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call